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Harvey Hecht, MD,* Y. Chandrashekhar, MD,y Jagat Narula, MD, PHD*P hysicians deal with uncertainty all the timeand chest pain in the emergency department(ED) is a typical example. Traditionally, coro-
nary artery disease (CAD), pulmonary embolism
(PE), and aortic dissection can present as chest pain,
and the consequences of a missed diagnosis can be
devastating, with the potential for rapid deterioration,
and serious risk of morbidity and mortality. Moreover,
because these conditions are also common causes of
malpractice claims, an extra layer of concern and
possible overinvestigation may be added. This has
led to a computed tomography angiography (CTA)
strategy—the triple rule out (TRO) or a single test for
all 3 conditions—out of an abundance of caution.
Of course, CTA for a single diagnosis is routinely
used in the ED. It is commonly used to exclude aortic
dissection and CAD. It is often the ﬁrst-line strategy
to rule out pulmonary embolism (1,2), which is difﬁ-
cult to diagnose clinically and is often missed. Other
tests for PE such as ventilation/perfusion scans are
not robust and are diagnostic less than one-half
of the time (2). This results in a low threshold for
computed tomography (CT) evaluation but has a low
positive yield with a very high negative predictive
value (3). Overuse of CTA for PE in the ED is under-
standable but may be detrimental by picking up PEs
that may not have immediate clinical relevance
(1). An interesting paper (4) and the accompanying
editorial (5) in this issue of iJACC on TRO by CTA for
chest pain ED evaluation raise broader questions
about the appropriate amount of testing in thisFrom the *Icahn School of Medicine at Mount Sinai, New York, New York;
and the yUniversity of Minnesota, Minneapolis, Minnesota. The authors
have reported that they have no relationships relevant to the contents
of this paper to disclose.setting. This multicenter study (4) strongly suggests
that TRO should not be the standard of care because
of the low diagnostic yield, additional contrast and
radiation, as well as poorer image quality, echoing
the conclusions of a meta-analysis (6).
There is ongoing concern about the overuse
of medical technology and its adverse conse-
quences, including avoidable harm, wasted time and
resources, burgeoning cost, and possibly poorer out-
comes. The less is more philosophy has very nicely
highlighted these issues (7). A retrospective analysis
of 421,774 insurance claims (8) extended the less is
more approach to all ED noninvasive testing based on
signiﬁcantly higher odds of cardiac catheterization
and revascularization procedures without improve-
ment in clinical outcomes accompanying stress
testing and CTA (8). The adverse event rate has been
demonstrated to be only 0.18% in 11,230 patients
admitted or sent to an observation unit after an ED
chest pain visit with normal serial troponins and
electrocardiogram, and it has been suggested that
patients be discharged straight from the ED without
further evaluation (9). There are some data showing
that the use of CTA in pulmonary embolism may
also be a strong example of the need for the less
is more philosophy (10), and the Burris et al. (4) paper
brings the same evidence into the chest pain syn-
drome in the ED.
What will be the evolution of diagnostic testing in
the face of ever-increasing technology? It would seem
that the weight of opinion in the future will favor
the less is more philosophy, but that transition will
depend only on the availability of high-quality
outcome data. Shotgun testing—a single test
screening for a number of potential diagnoses—will be
less favored than testing based on high-quality
“probability scores.” In addition, as medicine
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871transitions from a volume-driven, fee-for-service
paradigm to an accountable care outcomes approach
with no reward (and possible ﬁnancial disincentive)
for additional testing, the use of noninvasive imaging
is likely to decrease in general and, more speciﬁcally,
in the ED where a larger percentage of unpaid care
would render the economics more unfavorable.
The introduction of high-sensitivity troponins into
the ED paradigm might accelerate the decline of
noninvasive testing by its promise of extraordinarily
high negative predictive value for an acute coronary
syndrome delivered within a dramatically shortened
time frame (11), and noninvasive testing would
likely be reserved for the as yet to be determined
equivocal troponin range. Thus, unless further ran-
domized, controlled trials yield better outcomes for
the noninvasive testing strategy (a highly unlikely
eventuality), the application of the “more the
merrier” strategy of testing in the ED to patients in
whom CAD or a related condition for chest pain is
thought to be the greatest consideration appears
unlikely.
However, it is not out of place to consider more
from less. As Burris et al. (4) have demonstrated, the
yield from TRO was overwhelmingly cardiac (15.2%)
compared to aortic dissection (1.7%) and pulmonary
embolism (1.1%). Even though dissection and embo-
lism were very likely not the primary diagnoses, it is
reasonable to anticipate similar ﬁndings in CTA in
which they were the primary targets. History and
physical exam remain notoriously inaccurate in dis-
tinguishing between cardiac, aortic, and pulmonary
artery etiologies, and only w10% of pulmonary em-
bolism studies have positive ﬁndings (12). Exact
numbers are not available for dissection studies,
but it is likely to be even lower because there areapproximately just 2,000 new dissections reported
annually (13). Thus, analysis of the coronary arteries
(which are always in the ﬁeld of view) would be ideal
in pulmonary embolism and dissection studies, i.e.,
deriving more information from an indicated test.
However, the need for electrocardiographic gating
will increase the radiation dose and cannot be
routinely advocated with the current technology.
Nonetheless, ongoing and future CT technology de-
velopments, with radiation dose and contrast re-
ductions, may enable a single gated acquisition
protocol for scanning the entire chest with very low
radiation without loss of quality—i.e., a TRO without
the limitations of the Burris et al. (4) study. Other
modalities are improving rapidly as well and cardiac
magnetic resonance with angiography might provide
the same beneﬁts without radiation in selected
patients.
Thus, in the current era of maximizing yield
from available resources and avoiding unnecessary
testing, the versatility and radiation sparing of
future CT scanning technologies may provide in-
valuable coronary information from appropriately
indicated dissection and pulmonary embolism
studies without additional cost or harm. Of course,
as in any medical decision making, outcome studies
demonstrating the objective beneﬁts of this ap-
proach will be required. We need to hear what you
think; do you see an increasing role for CTA in the
ED or do you think otherwise. Please write to us
at jaccimg@acc.org.
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